NTIDs # HVDs (or not?) [Design Issues]

posted by Dr_Dan  – Germany, 2010-06-08 14:24 (5448 d 07:49 ago) – Posting: # 5468
Views: 9,026

Hi Helmut

❝ If we are talking about immunosuppressants, we are talking about a study in patients, right? Steady state too. Likely parallel design – it’s unethical to interrupt treatment by a washout.


If you investigate steady state PK you can do an "active washout" without interrupting treatment.

Regards
Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,671 registered users;
171 visitors (0 registered, 171 guests [including 8 identified bots]).
Forum time: 22:14 CEST (Europe/Vienna)

Young man, in mathematics you don’t understand things.
You just get used to them.    John von Neumann

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5